Doctor Al Bellibas
The Medicines Company, Parsippany (United States of America)
Body weight does not affect systemic PK exposure parameters of MDCO-216 in healthy volunteers and CAD patients
Event: ESC Congress 2016
Topic: CAD and comorbidities
Session: Comorbidities and risk for CAD
ESC 365 is supported by
